Researcher index

Authors in the psilocybin and psilocin literature

Search researcher names, inspect publication history, find recurring topics, and create author watch alerts without collecting unverified contact lists.

De Martin S

28 indexed publications match this author name.

ORCID: Not found in stored metadata
OpenAlex: Not found in stored metadata

Author watchlist

Create a confirmed email alert for new publications matching this author.

Topics

Receptor Pharmacology 12 Pharmacology 11 Depression 9 Mechanism of Action 8 Safety 8 Animal Study 6 Clinical Trial 6 Review Article 6 Anxiety 5 Treatment-Resistant Depression 4 OCD 4 Adverse Events 4

Journals

Journal of Hepatology 3 Digestive and Liver Disease 3 Cureus 2 Drugs and Drug Candidates 1 ClinicalTrials.gov 1 Journal of Medicinal Chemistry 1 The Study of Phenomena Related to Health 1 Trends in pharmacological sciences 1

Publication history

Exploring the In Vitro Effect of Psilocybin on the Composition and Metabolic Activity of Gut Microbiota in Individuals with Severe AnxietyDrugs and Drug Candidates · 2026-08-12 A Phase III, Multicentre, Randomised, Double-blind, Controlled Study to Investigate the Efficacy, Safety, and Tolerability of Two Administrations of COMP360 in Participants With Treatment-resistant DepressionClinicalTrials.gov · 2026-08-10 SAT-219 Hepatic 5-HT2B receptor antagonism mediates the anti-steatotic and antifibrotic effects of psilocybin in preclinical MASH modelsJournal of Hepatology · 2026-05-01 Design, Synthesis, and Pharmacokinetic Profiling of Fluorinated Reversible N -Alkyl Carbamate Derivatives of Psilocin for Sub-Hallucinogenic Brain ExposureJournal of Medicinal Chemistry · 2026-02-12 COMPARATIVE EFFICACY AND ACCEPTABILITY OF PSILOCYBIN-KETAMINE AND TYPICAL ANTIDEPRESSANTS FOR MAJOR DEPRESSIVE DISORDER MANAGEMENT: A NETWORK META-ANALYSISThe Study of Phenomena Related to Health · 2026-01-01 Emerging mechanisms of psilocybin-induced neuroplasticity.Trends in pharmacological sciences · 2025-11-01 Single-dose (10 mg) psilocybin reduces symptoms in adults with obsessive-compulsive disorder: A pharmacological challenge study.Comprehensive psychiatry · 2025-10-01 Psilocybin during the postpartum period induces long-lasting adverse effects in both mothers and offspring.Nature communications · 2025-09-30 Rapid and sustained antidepressant effects of vaporized N,N-dimethyltryptamine: a phase 2a clinical trial in treatment-resistant depression.Neuropsychopharmacology: official publication of the American College of Neuropsychopharmacology · 2025-05-01 FRI-407 Adding the serotonergic agonist psilocybin to semaglutide as a novel combination therapy to cure MASLDJournal of Hepatology · 2025-04-30 Esse quam Videre: Critical Reflections on the Use of Psilocybin as an Adjuvant in Psychedelic-Assisted PsychotherapyPolymatheia. · 2025-02-15 Beneficial effect of the combination psilocybin-semaglutide in a murine model of Steatotic Liver DiseaseDigestive and Liver Disease · 2025-02-01 Direct effects of psilocybin on serotonin receptors regulate lipid accumulation in hepatic cells and adipocytesDigestive and Liver Disease · 2025-02-01 ANXIOLYTIC- AND PROCOGNITIVE-LIKE EFFECTS OF A30-DAY CHRONIC TREATMENT WITH A LOW NON-PSYCHEDELIC DOSE OF PSILOCYBIN IN C57BL/6J MICEThe international journal of neuropsychopharmacology · 2025-02-01 Experiential dimension of psilocybin-assisted therapy training: Necessity or hindrance to wider accessibility?Journal of Psychedelic Studies · 2025-01-21 Alternative therapy for neurological and psychiatric disorders using psilocybinSão Paulo Medical Journal · 2025-01-01 Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'.Cureus · 2025-01-01 Correction: Study Protocol for 'PsilOCD: A Pharmacological Challenge Study Evaluating the Effects of the 5-HT2A Agonist Psilocybin on the Neurocognitive and Clinical Correlates of Compulsivity'.Cureus · 2025-01-01 THU-285 Lownonpsychedelic dosed of psilocybin for the therapy of MASLDJournal of Hepatology · 2024-05-31 Rapid, biochemical tagging of cellular activity history in vivo.bioRxiv: the preprint server for biology · 2024-05-14 Safety and tolerability of inhaled N,N-Dimethyltryptamine (BMND01 candidate): A phase I clinical trial.European neuropsychopharmacology: the journal of the European College of Neuropsychopharmacology · 2024-03-01 Non-psychedelic doses of psilocybin as a novel therapeutic approach for MASLDDigestive and Liver Disease · 2024-02-01 Serotoninergic antidepressants combination in psilocybin-assisted psychotherapy: a case report.Frontiers in psychiatry · 2024-01-01 Behavioral effects of a 14-day repeated treatment with psilocybin at a low non-psychedelic dose: a preliminary study in C57BL/6J miceNeuroscience Applied · 2023-01-01 Self-Reported Efficacy of Treatments in Cluster Headache: a Systematic Review of Survey Studies.Current pain and headache reports · 2022-08-01 Psychedelics and Hallucinogens in Psychiatry: Finding New Pharmacological Targets.Current topics in medicinal chemistry · 2022-01-01 A whole genome atlas of 81 Psilocybe genomes as a resource for psilocybin production.Zenodo (CERN European Organization for Nuclear Research) · 2021-07-02 A utilização terapêutica da psilocibina como coadjuvante no tratamento do transtorno depressivo maior: uma revisão narrativa de literatura / The therapeutic use of psilocybin as an adjunct in the treatment of major depressive disorder: a narrative literature reviewBrazilian Journal of Health Review · 2021-05-03

Author directory